Merchant S - Search Results

1

Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis.

Ponce de Leon A, Merchant S, Raman G, Avendano E, Chan J, Tepichin Hernandez G, Sarpong E. Ponce de Leon A, et al. Among authors: merchant s. BMC Infect Dis. 2020 Mar 27;20(1):250. doi: 10.1186/s12879-020-04973-0. BMC Infect Dis. 2020. PMID: 32220233 Free PMC article.

2

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.

Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Raman G, et al. Among authors: merchant s. Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 29997889 Free PMC article.

3

Risk factors for Pseudomonas aeruginosa infections in Asia-Pacific and consequences of inappropriate initial antimicrobial therapy: A systematic literature review and meta-analysis.

Merchant S, Proudfoot EM, Quadri HN, McElroy HJ, Wright WR, Gupta A, Sarpong EM. Merchant S, et al. J Glob Antimicrob Resist. 2018 Sep;14:33-44. doi: 10.1016/j.jgar.2018.02.005. Epub 2018 Feb 15. J Glob Antimicrob Resist. 2018. PMID: 29454906

4

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.

Prabhu V, Foo J, Ahir H, Sarpong E, Merchant S. Prabhu V, et al. Among authors: merchant s. J Med Econ. 2017 Aug;20(8):840-849. doi: 10.1080/13696998.2017.1333960. Epub 2017 Jun 8. J Med Econ. 2017. PMID: 28532194 Free article.

5

Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States.

Tabak YP, Merchant S, Ye G, Vankeepuram L, Gupta V, Kurtz SG, Puzniak LA. Tabak YP, et al. Among authors: merchant s. J Hosp Infect. 2019 Oct;103(2):134-141. doi: 10.1016/j.jhin.2019.06.005. Epub 2019 Jun 19. J Hosp Infect. 2019. PMID: 31228511

6

Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients With Pseudomonas aeruginosa Infection.

Tartof SY, Kuntz JL, Chen LH, Wei R, Puzniak L, Tian Y, Im TM, Takhar HS, Merchant S, Lodise T. Tartof SY, et al. Among authors: merchant s. JAMA Netw Open. 2018 Oct 5;1(6):e183927. doi: 10.1001/jamanetworkopen.2018.3927. JAMA Netw Open. 2018. PMID: 30646267 Free PMC article.

7

Outcomes and management costs in patients hospitalized for skin and skin-structure infections.

Itani KM, Merchant S, Lin SJ, Akhras K, Alandete JC, Hatoum HT. Itani KM, et al. Among authors: merchant s. Am J Infect Control. 2011 Feb;39(1):42-9. doi: 10.1016/j.ajic.2010.03.018. Epub 2010 Jul 29. Am J Infect Control. 2011. PMID: 20673598

8

A Combination Antibiogram Evaluation for Pseudomonas aeruginosa in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in U.S. Hospitals.

Puzniak L, DePestel DD, Srinivasan A, Ye G, Murray J, Merchant S, DeRyke CA, Gupta V. Puzniak L, et al. Among authors: merchant s. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02564-18. doi: 10.1128/AAC.02564-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30917987 Free PMC article.

9

Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients.

Marwick C, Broomhall J, McCowan C, Phillips G, Gonzalez-McQuire S, Akhras K, Merchant S, Nathwani D, Davey P. Marwick C, et al. Among authors: merchant s. J Antimicrob Chemother. 2011 Feb;66(2):387-97. doi: 10.1093/jac/dkq362. Epub 2010 Oct 5. J Antimicrob Chemother. 2011. PMID: 20926396

10

Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.

Itani KM, Akhras KS, Stellhorn R, Quintana A, Budd D, Merchant S. Itani KM, et al. Among authors: merchant s. Pharmacoeconomics. 2009;27(5):421-30. doi: 10.2165/00019053-200927050-00006. Pharmacoeconomics. 2009. PMID: 19586079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

801 results

Search Page